Lidocaine 5% patch for localized neuropathic pain: progress for the patient, a new approach for the physician

Neuropathic pain (NeP) syndromes remain a difficult-to-treat medical entity. Despite a growing number of pharmacological and invasive analgesic therapies the results remain less than optimal because of insufficient analgesic efficacy and/or occurrence of pronounced side effects. Current guidelines p...

Descripción completa

Detalles Bibliográficos
Autores principales: Hans, Guy, Robert, Dominique, Verhulst, Johanna, Vercauteren, Marcel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262358/
https://www.ncbi.nlm.nih.gov/pubmed/22291487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262358/
https://www.ncbi.nlm.nih.gov/pubmed/22291487

Ejemplares similares